Nukkleus Financial Statements From 2010 to 2026

NUKK Stock  USD 3.81  0.44  10.35%   
Analyzing historical trends in various income statement and balance sheet accounts from Nukkleus' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nukkleus' valuation are summarized below:
Gross Profit
998.5 K
Market Capitalization
79.2 M
Enterprise Value Revenue
12.4045
Revenue
5.9 M
Earnings Share
(4.93)
There are currently one hundred twenty fundamental ratios for Nukkleus that can be evaluated and compared over time across peers in the industry. We recommend to check Nukkleus' last-minute fundamental drivers against the all of the trends between 2010 and 2026. Enterprise Value is expected to rise to about 20.3 B this year, although the value of Market Cap will most likely fall to about 3.4 M.

Nukkleus Total Revenue

6.46 Million

Check Nukkleus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nukkleus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 K, Selling General Administrative of 10.4 M or Selling And Marketing Expenses of 48.6 K, as well as many indicators such as Price To Sales Ratio of 0.74, Dividend Yield of 6.0E-4 or Days Sales Outstanding of 2.36. Nukkleus financial statements analysis is a perfect complement when working with Nukkleus Valuation or Volatility modules.
  
Build AI portfolio with Nukkleus Stock
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Nukkleus Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities2.3 M3.9 M2.1 M
Slightly volatile
Total Current Liabilities8.5 M8.1 M3.4 M
Slightly volatile
Common Stock Shares Outstanding1.9 MM113.5 M
Pretty Stable
Other Stockholder Equity40.3 M38.3 M10.9 M
Slightly volatile
Total Liabilities9.8 M9.3 M3.8 M
Slightly volatile
Common Stock22824012.1 K
Very volatile
Short and Long Term Debt Total4.8 M4.6 M1.6 M
Slightly volatile
Capital Stock17918817.7 K
Slightly volatile
Current Deferred Revenue153.5 K191.3 K95.5 K
Slightly volatile

Nukkleus Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization15.1 K15.9 K460.2 K
Pretty Stable
Selling General Administrative10.4 M9.9 M3.1 M
Slightly volatile
Selling And Marketing Expenses48.6 K51.2 K98.7 K
Pretty Stable
Total Revenue6.5 M6.8 M10.5 M
Slightly volatile
Other Operating Expenses16.6 M23.1 M15.2 M
Slightly volatile
Cost Of Revenue5.4 M5.7 M10.3 M
Slightly volatile
Total Operating Expenses18.3 M17.5 M6.4 M
Slightly volatile

Nukkleus Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow38.7 K40.8 K344.6 K
Slightly volatile
Change To Operating Activities4.2 MM1.5 M
Slightly volatile
Depreciation15.1 K15.9 K350 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.740.784.1 K
Slightly volatile
Dividend Yield6.0E-46.0E-47.0E-4
Slightly volatile
Days Sales Outstanding2.362.4920.2301
Very volatile
Average Payables277.3 K264.1 K98.6 K
Slightly volatile
Stock Based Compensation To Revenue0.04240.04470.4405
Slightly volatile
Capex To Depreciation0.01660.01580.005
Slightly volatile
EV To Sales1.481.564.1 K
Slightly volatile
Payables Turnover9.379.87182
Very volatile
Sales General And Administrative To Revenue1.341.672.2329
Slightly volatile
Capex To Revenue0.00170.00230.0018
Slightly volatile
Cash Per Share0.340.320.0979
Slightly volatile
Days Payables Outstanding74.2138.2955.0371
Slightly volatile
Intangibles To Total Assets0.02140.02250.5884
Slightly volatile
Current Ratio0.150.161.896
Slightly volatile
Receivables Turnover15915244.704
Slightly volatile
Capex Per Share0.00440.00480.0049
Slightly volatile
Average Receivables895.6 KM1.1 M
Slightly volatile
Revenue Per Share3.233.081.2587
Slightly volatile
Interest Debt Per Share2.492.370.603
Slightly volatile
Debt To Assets3.843.661.3841
Slightly volatile
Operating Cycle2.362.4920.2301
Very volatile
Days Of Payables Outstanding74.2138.2955.0371
Slightly volatile
Ebt Per Ebit0.980.541.0818
Very volatile
Quick Ratio0.150.161.896
Slightly volatile
Net Income Per E B T1.11.151.016
Slightly volatile
Cash Ratio6.0E-46.0E-41.2451
Slightly volatile
Days Of Sales Outstanding2.362.4920.2301
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.131.1924.3054
Slightly volatile
Debt Ratio3.843.661.3841
Slightly volatile
Price Sales Ratio0.740.784.1 K
Slightly volatile
Asset Turnover6.566.914.377
Very volatile

Nukkleus Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.4 M3.6 M6.4 B
Very volatile
Enterprise Value20.3 B19.4 B12.5 B
Slightly volatile

Nukkleus Fundamental Market Drivers

About Nukkleus Financial Statements

Nukkleus investors utilize fundamental indicators, such as revenue or net income, to predict how Nukkleus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue191.3 K153.5 K
Total Revenue6.8 M6.5 M
Cost Of Revenue5.7 M5.4 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 1.67  1.34 
Revenue Per Share 3.08  3.23 
Ebit Per Revenue(2.16)(2.27)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.93)
Revenue Per Share
3.422
Quarterly Revenue Growth
(0.95)
Return On Assets
(3.97)
Return On Equity
(7.42)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.